Cargando…

5588995 COMPARATIVE EFFICACY AND SAFETY OF PHARMACOLOGICAL INTERVENTIONS FOR SICKLE CELL DISEASE IN CHILDREN AND ADOLESCENTS: A NETWORK META-ANALYSIS

Detalles Bibliográficos
Autores principales:	Tonin, F.S., Ginete, C., Ferreira, J., Delgadinho, M., Fernandez-Llimos, F., Brito, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	e-Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112610/ http://dx.doi.org/10.1097/01.HS9.0000928488.59931.31

Ejemplares similares

Efficacy and safety of pharmacological interventions for managing sickle cell disease in children and adolescents: protocol for a systematic review with network meta-analysis
por: Tonin, Fernanda S, et al.
Publicado: (2023)

5589865 PRELIMINARY FINDINGS FROM THE FOLLOW-UP OF PREGNANT SICKLE CELL DISEASE PATIENTS IN LUANDA, ANGOLA.
por: Brito, M., et al.
Publicado: (2023)

P101: GUT MICROBIOTA IMPACT ON ANGOLAN CHILDREN WITH SICKLE CELL DISEASE
por: Brito, M, et al.
Publicado: (2022)

P-057: GENETIC VARIABILITY AND DISEASE SEVERITY IN A COHORT OF ANGOLAN SICKLE CELL DISEASE PATIENTS
por: M., BRITO, et al.
Publicado: (2022)

5595849 THE GUT MICROBIOME AND HYDROXYUREA EFFECT ON SICKLE CELL DISEASE CHILDREN FROM ANGOLA
por: Brito, M., et al.
Publicado: (2023)

PI-03: THE EFFECT OF HYDROXYUREA IN THE GUT MICROBIOME OF ANGOLAN CHILDREN WITH SICKLE CELL DISEASE
por: M., DELGADINHO, et al.
Publicado: (2022)

P-091: EFFECTS OF CARICA PAPAYA LEAF EXTRACTS IN TRANSCRIPTIONAL REGULATION OF FETAL HEMOGLOBIN
por: M., MENDES, et al.
Publicado: (2022)

P-069: EFFECTS OF QUERCETIN IN TRANSCRIPTIONAL REGULATION OF FETAL HEMOGLOBIN
por: B., CANTEIRO, et al.
Publicado: (2022)

Genotypic Diversity among Angolan Children with Sickle Cell Anemia
por: Delgadinho, Mariana, et al.
Publicado: (2021)

Microbial gut evaluation in an angolan paediatric population with sickle cell disease
por: Delgadinho, Mariana, et al.
Publicado: (2022)

Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?—A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children
por: Ginete, Catarina, et al.
Publicado: (2023)

5596737 RETINOPATHY IN EGYPTIAN PATIENTS WITH SICKLE CELL DISEASE
por: Hassan, T.H., et al.
Publicado: (2023)

5566409 IMPACT OF GENETIC VARIATIONS ON THROMBOTIC RISK OF SICKLE CELL DISEASE IN SAUDI PATIENTS
por: Alshabeeb, M.A., et al.
Publicado: (2023)

5613458 BLOOD MICROPARTICLES: A TOOL OF EVALUATING THE EFFECT OF TRANSFUSION IN SICKLE CELL DISEASE PATIENTS
por: Khalfaoui, K., et al.
Publicado: (2023)

5597199 AGEING WITH SICKLE CELL ANEMIA AND HOW TO FACE IT
por: Kreka, M.K., et al.
Publicado: (2023)

5613251 RAPIDLY PROGRESSING MOYAMOYA SYNDROME IN SICKLE CELL DISEASE -- CASE REPORT
por: Joana, J.L., et al.
Publicado: (2023)

5610603 CLINICAL AND GENETIC PREDICTORS OF SICKLE CELL NEPHROPATHY IN MALAWI
por: Banda, K.H.B., et al.
Publicado: (2023)

5610614 ASSESSING PHYSICAL, SOCIAL AND EMOTIONAL IMPACT OF SICKLE CELL DISEASE IN PORTUGUESE PATIENTS: AN OBSERVATIONAL, MULTICENTER STUDY (ASCEND)
por: Christopher Saunders, C.S., et al.
Publicado: (2023)

How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia
por: Delgadinho, Mariana, et al.
Publicado: (2022)

P124: EFFICACY OF NON-PHARMACOLOGICAL INTERVENTIONS TO REDUCE PAIN IN CHILDREN WITH SICKLE CELL DISEASE: A SYSTEMATIC REVIEW
por: Vuong, C, et al.
Publicado: (2022)

5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT
por: Levin, C.L., et al.
Publicado: (2023)

5613386 CELEBRATING THE SICKLE CELL DISEASE WORLD DAY ON JUNE 19TH AFTER TWO YEARS OF PANDEMIC: MY LIFE WITH SCD, PATIENTS’ PERSPECTIVE
por: Maran, J.E.M., et al.
Publicado: (2023)

5613341 REAL-WORLD CHANGES IN KIDNEY FUNCTION FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANAEMIAS RECEIVING IRON CHELATION THERAPY IN THE US
por: Sunil Bhandari, S.B., et al.
Publicado: (2023)

5613019 THE CO-EXISTENCE OF SICKLE CELL DISEASE WITH NEUROFIBROMATOSIS: A CASE REPORT
por: Crombie, K., et al.
Publicado: (2023)

5610178 SURVIVAL AND COMPLICATIONS IN PATIENTS WITH HEMOGLOBINOPATHIES: THE EXPERIENCE OF A SINGLE DEPARTMENT OF THALASSEMIA AND SICKLE DISEASE
por: Xydaki, X.A., et al.
Publicado: (2023)

5597164 BURDEN AND RISK FACTOR TO ACUTE MYOCARDIAL ISCHAEMIA IN CHILDREN WITH SICKLE CELL ANAEMIA
por: Adeniyi, O.D., et al.
Publicado: (2023)

P-036: PIEZO1 ACTIVATION AUGMENTS SICKLING PROPENSITY AND THE ADHESIVE PROPERTIES OF SICKLE RED BLOOD CELLS
por: N., CONRAN, et al.
Publicado: (2022)

5567917 COST COMPARISON OF TRANSFUSION CHOICES IN OMAN FOR PATIENTS SUFFERING FROM SICKLE CELL DISEASE
por: Sweerts, L., et al.
Publicado: (2023)

5610107 LIVE OUTCOMES AND BIOMETRIC MONITORING: POTENTIAL IMPLICATIONS FOR PATIENT QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023)

5607560 AN AUDIT OF COMPLIANCE WITH NEONATAL SCREENING GUIDELINES IN NEONATES DIAGNOSED WITH SICKLE CELL DISEASE IN SOUTH WALES
por: Pasha, S.R.P., et al.
Publicado: (2023)

5607225 ADDITION OF THERAPEUTIC PLASMA EXCHANGE TO RED CELL EXCHANGE IMPROVES OUTCOMES OF FAT EMBOLISM SYNDROME IN SICKLE CELL DISEASE
por: Tsitsikas, D.A., et al.
Publicado: (2023)

5610131 A STANDARDISED LANGUAGE TAG PROTOCOL AND WORKFLOW FOR DEVELOPING AND MANAGING MULTILINGUAL ONTOLOGIES: SHOWCASING THE FRENCH SICKLE CELL DISEASE ONTOLOGY (SCDO)
por: Hotchkiss, J., et al.
Publicado: (2023)

Pharmacology and Safety, etc.
Publicado: (2020)

5612390 CORRELATION OF DOPPLER DEFINED ELEVATED PULMONARY PRESSURE WITH LABORATORY PARAMETERS IN ADULT PATIENTS WITH SICKLE CELL DISEASE - A RETROSPECTIVE STUDY
por: Samal, P.S.S., et al.
Publicado: (2023)

5597311 THE EFFECT OF MUSIC AND DANCE AS FORMS OF PHYSICAL ACTIVITY ON THE HEALTH STATUS OF PEOPLE WITH SICKLE CELL DISEASE: A SYSTEMATIC REVIEW OF THE LITERATURE
por: Van Gerven, A., et al.
Publicado: (2023)

5613165 INVESTIGATING VARIANTS ASSOCIATED WITH QUANTITATIVE RED BLOOD CELL PHENOTYPES FROM TOPMED PREDICTIONS IN AFRICAN SICKLE CELL DISEASE POPULATIONS.
por: Samie, N., et al.
Publicado: (2023)

5588568 ASSOCIATION OF MANNOSE-BINDING LECTIN SERUM LEVEL AND PROMOTER GENE VARIANTS RS7096206 AND RS10031251 WITH FREQUENCY OF VASO-OCCLUSIVE EVENTS IN SICKLE CELL DISEASE PATIENTS; AN EGYPTIAN CROSS-SECTIONAL STUDY
por: El-Ghamrawy, M., et al.
Publicado: (2023)

P-065: IMPACT OF SOCIOECONOMIC FACTORS ON COGNITIVE FUNCTION IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE
por: A., DARBARI, et al.
Publicado: (2022)

5575938 DIETARY PATTERN, SOCIO-DEMOGRAPHIC CHARACTERISTICS AND NUTRITIONAL STATUS OF PREGNANT WOMEN ATTENDING BARAU DIKKO TEACHING HOSPITAL AND THE NEED TO DEVELOP RECOMMENDED DIETARY ALLOWANCE AND DIETARY REFERENCE INTAKES FOR SICKLE CELL DISEASE PATIENTS
por: Sunday, A.D.S., et al.
Publicado: (2023)

P-089: EVALUATION OF SAFETY AND EFFICACY OF HBS-SAILIN®: A POTENT INGENIOUS ANTI-SICKLING AGENT THAT REDUCES PAIN AND IMPROVES THE QUALITY OF LIFE IN SICKLE CELL PATIENTS.
por: S., BHATT, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6vdceg5ajjh3e175rl5j5stc5a